A Clinical Study To Assess The Usefulness Of Causation In Homoeopathic Prescription In The Management Of Patients Suffering From Chronic Urticaria With Homoeopathic Remedies
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- To evaluate the effect of Individualized homoeopathic medicine based on causation in the management of Chronic Urticaria using Urticaria Activity Score over 7 days(UAS7) before and after the treatment
Study Overview
Brief Summary
Chronic urticaria is a common, relapsing dermatological condition characterized by the presence of recurrent wheals, itching, and occasional angioedema, significantly affecting the quality of life of patients. Identification of causative factors plays an important role in the homoeopathic system of medicine, as causation is considered a key element in individualizing the prescription and selecting the most appropriate remedy.
The present study is planned to assess the usefulness of causation in homoeopathic prescription in the management of patients suffering from chronic urticaria. Patients fulfilling the inclusion and exclusion criteria will be enrolled from the outpatient department. Detailed case taking will be carried out with special emphasis on eliciting causative factors, and individualized homoeopathic medicines will be prescribed accordingly.
The effectiveness of the treatment will be evaluated using the Urticaria Activity Score over 7 days (UAS7) to assess disease activity, along with the Chronic Urticaria Quality of Life Questionnaire (CU-Q2oL) to evaluate the impact of the disease and its treatment on patients’ quality of life. Assessment will be done at baseline, after 3 months, and at 6 months to observe changes in the severity and frequency of urticarial symptoms as well as quality of life parameters. The findings of the study are expected to provide clinical evidence regarding the role of causation in homoeopathic prescribing for chronic urticaria.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Masking
- None
Eligibility Criteria
- Ages
- 18.00 Year(s) to 65.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •1.Patients clinically diagnosed with chronic urticaria.
- •2.Participants of any gender, including male, female, and transgender individuals, will be eligible for the study.
- •3.Patients belonging to the age group 18 years to 65 years.
- •4.Literate patients who can read English or Hindi will be included.
- •5.Illiterate patients will also be enrolled, and investigators will assist them in completing the questionnaires or scales while ensuring adequate privacy.
- •6.Participants who will provide informed consent, comply with the study protocols, and attend all scheduled follow-up visits.
Exclusion Criteria
- •1.Patients suffering from severe systemic illnesses or any other life-threatening conditions.
- •2.Patients with a history of severe anaphylactic shock.
- •3.Pregnant and lactating women.
- •4.Patients who refuse to give informed consent and not willing to come for follow ups.
Outcomes
Primary Outcomes
To evaluate the effect of Individualized homoeopathic medicine based on causation in the management of Chronic Urticaria using Urticaria Activity Score over 7 days(UAS7) before and after the treatment
Time Frame: 12 weeks to 24 weeks
Secondary Outcomes
- To evaluate the changes in the quality of life of patients suffering from chronic urticaria using Chronic Urticaria Quality of Life Questionnaire(CU-Q2oL)(12 weeks to 24 weeks)
Investigators
Dr Amit Kumar
State National Homoeopathic Medical College and Hospital